Skip to main content
. 2017 Apr;112(4):237–246. doi: 10.1590/0074-02760160173

TABLE III. Percentage case reduction estimated by the regression model for children aged < 1 year and children aged 1-4 years in Brazil and regions in the years following the introduction of meningococcal C vaccination.

Brazil < 1 year 1-4 years


Variation in MDC cases (%) CI 95% Variation in MDC cases (%) CI 95%
2010 1.5 (119.6, 22.5) -4.2 (-23.2, 14.8)
2011 -54.6 (-75.3, -33.8) -21.8 (-40.8, -2.8)
2012 -70.9 (-91.7, -50.2) -57.6 (-76.8, -38.4)
2013 -70.7 (-91.6, -49.8) -74.5 (-92.7, -56.2)
2011-2013 -65.7 (-86.5, -44.9) -51.8 (-70.6, -33.0)
Northeast        
2010 -28.2 (-52.5, -3.9) -44.8 (-90.9, 1.2)
2011-2013 -56.7 (-76.0, -37.4) -55.0 (-97.2, -12.9)
Midwest        
2010 -55.0 (-97.0, -13.1) -9.4 (-46.5, 27.8)
2011-2013 -83.7 (-100.0, -51.1) -73.4 (-100.0, -39.1)
Southeast        
2010 13.5 (-2.7, 29.7) 4.5 (-6.8, 15.8)
2011-2013 -65.4 (-82.2, -12.2) -42.9 (-72.3, -13.5)
South        
2010 4.2 (-34.7, 43.0) -32.6 (-75.5, 10.3)
2011-2013 -60.1 (-91.7, -28.5) -44.0 (-88.4, 0.4)

CI: confidence interval; MDC: meningococcal disease serogroup C.